Totsika, Vaso, Yang, Zhixing, Turner, Lauren, Kohn, Charmaine, Hassiotis, Angela, Kennedy, Eilis, Absoud, Michael, McNamara, Rachel ORCID: https://orcid.org/0000-0002-7280-1611, Randell, Elizabeth ORCID: https://orcid.org/0000-0002-1606-3175, Levitt, Sophie, Grant, Gemma, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Jacobs, Lauris, Di Santo, Cristina, Buckley, Claire, Hignett, Emma and Liew, Ashley
2025.
Mapping the pathway and support offered to children with an intellectual disability referred to specialist mental health services in the UK.
BJPsych Bulletin
49
(3)
, pp. 157-162.
10.1192/bjb.2024.63
|
|
|
Kohn, Charmaine, Turner, Lauren, Yang, Zhixing, Absoud, Michael, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Gomes, Manuel, Grant, Gemma, Hassiotis, Angela, Kennedy, Eilis, Levitt, Sophie, McNamara, Rachel ORCID: https://orcid.org/0000-0002-7280-1611, Randell, Elizabeth ORCID: https://orcid.org/0000-0002-1606-3175 and Totsika, Vasiliki
2024.
Remotely delivered video interaction guidance for families of children with an intellectual disability referred to specialist mental health services: protocol for a feasibility randomized controlled trial.
JMIR Research Protocols
13
, e54619.
10.2196/54619
|
|
|
Randell, Elizabeth ORCID: https://orcid.org/0000-0002-1606-3175, Nollett, Claire ORCID: https://orcid.org/0000-0001-6676-4933, Totsika, Vaso, Kennedy, Eilis, Johnson, Sean, Meister, Lena, Smallman, Kim ORCID: https://orcid.org/0000-0002-9283-8120, McNamara, Rachel ORCID: https://orcid.org/0000-0002-7280-1611, Segrott, Jeremy ORCID: https://orcid.org/0000-0001-6215-0870, Wakelyn, Jenifer, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, McKay, Kathy, Bordea, Ekaterina, Wilkins, David ORCID: https://orcid.org/0000-0003-2780-0385 and Mortimer, Ema
2024.
Watch Me Play! A pilot feasibility study of a remotely- delivered intervention to promote mental health resilience
for children (aged 0-8) across UK early years and children's services.
[Project Report].
Foundations.
|
|
|
Ajakaiye, Anu, Brogden, Elena, Murphy, Jamie, Peters, Christopher, Frost, Jonathan, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Hudson, Emma, Perry, Kitrick, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Hamilton, Rebecca, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Arndell, Karen, Gwynne, Sarah, Torkington, Jared and Jones, Sadie
2024.
Pressurised intraperitoneal aerosolised chemotherapy in the management of cancer of the colon, ovary and stomach: phase II randomised controlled trial of efficacy in peritoneal metastases.
Presented at: International Society of Gynecologic Cancer 2024 Annual Global Meeting,
Dublin, Ireland,
16-18 October 2024.
International Journal of Gynecological Cancer.
, vol.34
BMJ Publishing Group,
A350-A351.
10.1136/ijgc-2024-IGCS.611
|
|
|
Murphy, Alexander D, Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, White, Ann, Irving, Alys, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Ray, Ruby, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Mahmood, Reem D., Karanth, Suman, Zhou, Cong, Pugh, Julia, Wheeler, Chelsey, Roberts, Victoria, Arnetoli, Giorgio, Salih, Zena, Hasan, Jurjees, Mitchell, Claire, Morgan, Robert D., Clamp, Andrew R. and Jayson, Gordon C.
2024.
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.
International Journal of Gynecological Cancer
34
, pp. 1034-1040.
10.1136/ijgc-2024-005455
|
|
|
Jones, Sadie Esme Fleur, Hudson, Emma, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Murphy, Jamie, Peters, Christopher, Gwynne, Sarah, Frost, Jonathan, Brogden, Elena, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970 and Hamilton, Rebecca
2023.
Launching the PICCOS trial: PIPAC in cancers of the colon, ovary and stomach.
Presented at: European Society of Gynaecological Society Congress,
Istanbul, Turkey,
28 September - 01 October 2023.
International Journal of Gynecological Cancer.
BMJ Publishing Group,
10.1136/ijgc-2023-ESGO.690
|
|
Beresford, Mark, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Hudson, Zoe, Carucci, Margherita, Ingarfield, Kate, Gee, Julia ORCID: https://orcid.org/0000-0001-6483-2015, Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Kitson, Terri ORCID: https://orcid.org/0000-0001-6333-046X, Alchami, Fouad, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Hayward, Larrie, Hwang, David, Spensley, Saiqa, Waters, Simon, Wheatley, Duncan and Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496
2023.
Fulvestrant plus vandetanib versus placebo for the treatment of patients with metastatic breast cancer resistant to aromatase inhibitor therapy (FURVA): a multicentre, Phase 2, randomised controlled trial.
BJC Reports
1
(1)
, 13.
10.1038/s44276-023-00016-8
|
|
|
Kitson, Terri ORCID: https://orcid.org/0000-0001-6333-046X, Osborne, Emma, Noble, Simon ORCID: https://orcid.org/0000-0001-5425-2383, Pease, Nikki, Alikhan, Raza, Bryant, Catherine, Groves, Tristan, Wallace, Rebecca, Walker, Sarah, Seddon, Kathy, Smith, Deb, Raisanen, Lawrence, Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Thomas, Ian, Upton, Laura and Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052
2023.
HIDDEN2: Study protocol for the hospital deep vein thrombosis detection study in patients with cancer receiving palliative care.
BMJ Open
13
(9)
, e073049.
10.1136/bmjopen-2023-073049
|
|
|
Fennell, Dean A., Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, Lester, Jason, Danson, Sarah, Blackhall, Fiona, Nicolson, Marianne, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Gardner, Georgina, White, Ann, Griffiths, Gareth and Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052
2022.
Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial.
EClinicalMedicine
52
, 101595.
10.1016/j.eclinm.2022.101595
|
|
|
Howell, Sacha J., Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Carucci, Margherita, Ingarfield, Kate, Butler, Rachel, Morgan, Sian, Meissner, Magdalena, Bale, Catherine, Bezecny, Pavel, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, De Bruin, Elza C., Schiavon, Gaia, Foxley, Andrew and Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496
2022.
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial.
The Lancet Oncology
23
(7)
, pp. 851-864.
10.1016/s1470-2045(22)00284-4
|
|
|
Fennell, Dean A., Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, Lester, Jason, Danson, Sarah, Taylor, Paul, Sheaff, Michael, Rudd, Robin M., Gaba, Aarti, Busacca, Sara, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Gardner, Georgina, Darlison, Liz, Poile, Charlotte, Richards, Cathy, Jordan, Peter-Wells, Griffiths, Gareth and Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052
2022.
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial.
eClinicalMedicine
48
, 101432.
10.1016/j.eclinm.2022.101432
|
|
|
Jones, Rob, Crabb, Simon, Chester, John ORCID: https://orcid.org/0000-0002-7830-3840, Elliott, Tony, Huddart, Robert, Birtle, Alison, Evans, Linda, Lester, Jason, Jagdev, Satinder, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Huang, Chao, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873 and Griffiths, Gareth
2020.
A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer patients not suitable to receive cisplatin.
BJU International
126
(2)
, pp. 292-299.
10.1111/bju.15096
|
|
|
Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Carucci, Margherita, Cox, Catrin, Butler, Rachel, Alchami, Fouad, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Bale, Catherine, Bezecny, Pavel, Joffe, Johnathan, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, Foxley, Andrew and Howell, Sacha J.
2020.
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial.
Lancet Oncology
21
(3)
, pp. 345-347.
10.1016/S1470-2045(19)30817-4
|
|
|
Lester, Jason F, Casbard, Angela C ORCID: https://orcid.org/0000-0001-6241-3052, Al-Taei, Saly, Harrop, Richard, Katona, Lajos ORCID: https://orcid.org/0000-0001-9929-0543, Attanoos, Richard L, Tabi, Zsuzsanna and Griffiths, Gareth O
2018.
A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma - the SKOPOS trial.
OncoImmunology
7
(12)
, e1457597.
10.1080/2162402X.2018.1457597
|
|
|
Gillespie, David ORCID: https://orcid.org/0000-0002-6934-2928, Farewell, Daniel ORCID: https://orcid.org/0000-0002-8871-1653, Barrett-Lee, Peter, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Hawthorne, Anthony Barney, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Murray, Nick, Probert, Chris, Stenson, Rachel and Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631
2017.
The use of randomisation-based efficacy estimators in non-inferiority trials.
Trials
18
(1)
, 117.
10.1186/s13063-017-1837-3
|
|
|
Jones, Robert J., Crabb, S. J., Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840, Elliott, T., Huddart, R. A., Birtie, A. J., Evans, L., Lester, Jason Francis, Huang, Chao, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873 and Griffiths, Gareth
2016.
TOUCAN: A randomised phase II trial of carboplatin and gemcitabine plus /- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin [Abstract].
American Journal of Clinical Oncology
34
(S25)
, 448.
|
|
Geldart, Thomas, Chester, John ORCID: https://orcid.org/0000-0002-7830-3840, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Cowles, Robert, Evans, Jessica and Griffiths, Gareth
2015.
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma.
European Urology
67
(4)
, pp. 599-602.
10.1016/j.eururo.2014.11.003
|
|
|
| Noble, Simon, Smith, Joanna D., Baillie, Jessica, Baglin, T., Griffiths, Gareth O., Casbard, Angela, Cohen, Deborah, Fitzmaurice, D., Hood, Kerenza, Rose, P., Cohen, A., Johnson, Miriam, Maraveyas, A., Bell, John, Toone, H. and Nelson, Annmarie 2014. ALICAT: Anticoagulation length in cancer associated thrombosis - a mixed-methods feasibility study. Thrombosis Research 133 (Supp 2) , S220-S220. 10.1016/S0049-3848(14)50032-1 |
|
Barrett-Lee, Peter, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Abraham, Jacinta, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Coleman, Robert, Simmonds, Peter, Timmins, Hayley, Wheatley, Duncan, Grieve, Robert, Griffiths, Gareth and Murray, Nick
2014.
Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial.
Lancet Oncology
15
(1)
, pp. 114-122.
10.1016/S1470-2045(13)70539-4
|
|
Smith, Joanna D. ORCID: https://orcid.org/0000-0003-4234-6686, Baillie, Jessica ORCID: https://orcid.org/0000-0002-4592-7286, Baglin, Trevor, Griffiths, Gareth O., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Cohen, David, Fitzmaurice, David A., Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Rose, Peter, Cohen, Alexander T., Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425 and Noble, Simon Ian Robert ORCID: https://orcid.org/0000-0001-5425-2383
2014.
A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study.
Trials
15
(1)
, 122.
10.1186/1745-6215-15-122
|
|
|
Noble, Simon Ian Robert ORCID: https://orcid.org/0000-0001-5425-2383, Baillie, Jessica ORCID: https://orcid.org/0000-0002-4592-7286, Smith, J., Baglin, T., Griffiths, G., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Cohen, D., Fitzmaurice, D., Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Rose, P., Cohen, A., Johnson, M., Maraveyas, A., Bell, J., Toone, H. and Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425
2014.
Anticoagulation length in cancer associated thrombosis: a mixed-methods feasibility study.
Presented at: International Conference on Thrombosis and Hemostasis Issues in Cancer,
Bergamo, Italy,
9-11 May 2014.
|
|
Harrop, Emily ORCID: https://orcid.org/0000-0003-2820-0023, Kelly, John, Neal, David, Dasgupta, Prokar, Basnett, Gillian, Huddart, Robert, Barham, Allan, Thompson, Colin, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Jundi, Hala, Griffiths, Gareth and Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425
2013.
‘Once I knew there was a choice, I wanted to exercise that choice': using qualitative methods to understand why patients decline surgical trials.
Trials
14
(S1)
, P9 (2013).
10.1186/1745-6215-14-s1-p9
|
|
|
Powell, James R., Dojcinov, Stefan, King, Louise, Wosniak, Sue, Gerry, Stephen, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Bailey, Hazel, Gallop-Evans, Eve and Maughan, Tim
2013.
Prognostic significance of hypoxia inducible factor-1α and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximab.
Leukemia & Lymphoma
54
(5)
, pp. 959-966.
10.3109/10428194.2012.733875
|
|
Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Wills, Lauren, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Crosby, Thomas David Lewis, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Griffiths, G.
2009.
Implementation of a QA RT substudy for SCOPE 1; Preliminary results for test cases [Abstract].
Clinical Oncology
21
(3)
, p. 255.
10.1016/j.clon.2009.01.001,
|
|
Llewelyn, C. A., Wells, A. W., Amin, M., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Johnson, A. J., Ballard, Sian, Buck, J., Malfroy, M., Murphy, M. F. and Williamson, L. M.
2009.
The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studies.
Transfusion Medicine
19
(2)
, pp. 89-98.
10.1111/j.1365-3148.2009.00911.x
|
|
Wells, A. W., Llewelyn, C. A., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Johnson, A. J., Amin, M., Ballard, Sian, Buck, J., Malfroy, M., Murphy, M. F. and Williamson, L. M.
2009.
The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service.
Transfusion Medicine
19
(6)
, pp. 315-328.
10.1111/j.1365-3148.2009.00933.x
|
|
Cooke, D., Hurel, S. J., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Steed, L., Walker, S., Meredith, S., Nunn, A. J., Manca, A., Sculpher, M., Barnard, M., Kerr, D., Weaver, J. U., Ahlquist, J. and Newman, S. P.
2009.
Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1cin insulin-treated diabetes (MITRE Study).
Diabetic Medicine
26
(5)
, pp. 540-547.
10.1111/j.1464-5491.2009.02723.x
|
|
Morgan, M. A., Lewis, W. G., Casbard, A. ORCID: https://orcid.org/0000-0001-6241-3052, Roberts, S. A., Adams, R. ORCID: https://orcid.org/0000-0003-3915-7243, Clark, G. W. B., Havard, T. J. and Crosby, T. D. L.
2009.
Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma.
British Journal of Surgery
96
(11)
, pp. 1300-1307.
10.1002/bjs.6705
|
|
Williamson, Lorna M., Stainsby, Dorothy, Jones, Hilary, Love, Elizabeth, Chapman, Catherine E., Navarrete, Cristina, Lucas, Geoff, Beatty, Cynthia, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Cohen, Hannah
2007.
The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.
Transfusion
47
(8)
, pp. 1455-1467.
10.1111/j.1537-2995.2007.01281.x
|
|
Ghevaert, Cedric, Campbell, Kate, Stafford, Prachi, Metcalfe, Paul, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Smith, Graham A., Allen, Dave, Ranasinghe, Edmund, Williamson, Lorna M. and Ouwehand, Willem H.
2007.
HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia.
Transfusion
47
(7)
, pp. 1296-1305.
10.1111/j.1537-2995.2007.01273.x
|
|
Williamson, M., Stainsby, D., Jones, H., Love, E., Chapman, C., Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052 and Cohen, H.
2006.
Haemovigilance reports of post-transfusion purpura and transfusion-associated graft-versus-host disease before and after implementation of universal leucocyte depletion in the UK.
Vox Sanguinis
91
(Supp 3)
, p. 15.
10.1111/j.0042-9007.2006.vox_v91_is3_mondaysessions.x
|
|
Stanworth, S. J., Dyer, C., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Murphy, M. F.
2006.
Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
Vox Sanguinis
91
(1)
, pp. 63-69.
10.1111/j.1423-0410.2006.00785.x
|
|
Davies, Amanda, Staves, Julie, Kay, Jonathan, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Murphy, Michael F.
2006.
End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses.
Transfusion
46
(3)
, pp. 352-364.
10.1111/j.1537-2995.2006.00729.x
|
|
Grover, M., Talwalkar, S., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Boralessa, H., Contreras, M., Boralessa, H., Brett, S., Goldhill, D. R. and Soni, N.
2006.
Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty.
Vox Sanguinis
90
(2)
, pp. 105-112.
10.1111/j.1423-0410.2006.00730.x
|
|
Buck, Jackie, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Llewelyn, Charlotte, Johnson, Tony, Davies, Sally and Williamson, Lorna
2005.
Preoperative transfusion in sickle cell disease: a survey of practice in England.
European Journal of Haematology
75
(1)
, pp. 14-21.
10.1111/j.1600-0609.2005.00412.x
|
|
Segal, H. C., Briggs, C., Kunka, S., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Harrison, P., Machin, S. J. and Murphy, M. F.
2005.
Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion.
British Journal of Haematology
128
(4)
, pp. 520-525.
10.1111/j.1365-2141.2004.05352.x
|
|
Allain, J.-P., Anokwa, M., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Owusu-Ofori, S. and Dennis-Antwi, J.
2004.
Sociology and behaviour of West African blood donors: the impact of religion on human immunodeficiency virus infection.
Vox Sanguinis
87
(4)
, pp. 233-240.
10.1111/j.1423-0410.2004.00578.x
|
|
McPherson, K., Metcalfe, M.A., Herbert, A., Maresh, M., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Hargreaves, J., Bridgman, S. and Clarke, A.
2004.
Severe complications of hysterectomy: the VALUE study.
BJOG - an International Journal of Obstetrics and Gynaecology
111
(7)
, pp. 688-694.
10.1111/j.1471-0528.2004.00174.x
|
|
Boralessa, H., Cockburn, H., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Contreras, M.
2004.
Review of transfusion practice in orthopaedic surgery.
Current Orthopaedics
18
(2)
, pp. 126-134.
10.1016/j.cuor.2003.11.001
|
|
Strang, J. I. G., Nunn, A. J., Johnson, D. A., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Gibson, D. G. and Girling, D. J.
2004.
Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up.
QJM: An International Journal of Medicine
97
(8)
, pp. 525-535.
10.1093/qjmed/hch086
|
|
Selden, C., Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Themis, M. and Hodgson, H. J.
2003.
Characterization of long-term survival of syngeneic hepatocytes in rat peritoneum.
Cell Transplantation
12
(6)
, pp. 569-578.
|
|
Maresh, M. J. A., Metcalfe, M. A., McPherson, Klim, Overton, C., Hall, V., Hargreaves, J., Bridgman, S., Dobbins, J. and Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052
2002.
The VALUE national hysterectomy study: description of the patients and their surgery.
BJOG: An International Journal of Obstetrics & Gynaecology
109
(3)
, pp. 302-312.
10.1016/S1470-0328(02)01282-X
|
|



Up a level